Internal Control · 2024
In this section9 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations2 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions2 items
- Counterparties & Transactions3 items
- Policy & Future Trends3 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
The Company recognizes the utmost importance of having a good internal control system in accordance with the principles of Good Corporate Governance, including international guidelines and frameworks for internal control, to ensure that the Company can achieve its objectives. The Board of Directors has appointed three Audit Committee members who are able to perform their duties effectively and independently to review the internal control system and monitor the adequacy and appropriateness of internal controls in various areas to support business operations, effectiveness and efficiency in operations, prevention or mitigation of risks, potential damages, and to ensure that the financial statements are accurate and reliable, as well as compliance with laws, rules and regulations related to the Company's business operations and the relevant criteria of the Stock Exchange of Thailand and the Securities and Exchange Commission.
The Audit Committee has considered the qualifications of Proud Advisory Company Limited, an outsourced company, to be the internal auditor for 2017, with Mr. Prit Buapuern as the Head of Internal Audit. The Committee is of the opinion that they have sufficient qualifications to act as the Company's internal auditor, including independence in performing audits and assessing the adequacy of the internal control system and compliance with the Company's systems. The Audit Committee then proposed to the Board of Directors for appointment. The internal auditor has coordinated with personnel from all departments of the Company, followed up on improvements to the internal control system in accordance with the recommendations of the internal auditor, including preparing an internal control assessment and audit report of the Company, and presenting the report to the Audit Committee meeting directly and continuously on a regular basis. (Details regarding the qualifications of the Head of Internal Audit are shown in Annex 2)
Within the scope of authority, duties, and responsibilities of the Audit Committee, the Audit Committee is responsible for reviewing the Company to have an appropriate and effective internal control and internal audit system, as well as approving the appointment, transfer, or termination of the Head of Internal Audit.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| The Committee of Sponsoring Organizations of the Treadway Commission (COSO) | The Company recognizes the importance of having a good internal control system to ensure that the Company has an appropriate and adequate internal control system in accordance with the principles of good corporate governance in overseeing business operations. To ensure efficient, transparent, and auditable operations, as well as to prevent risks and damages that may occur to the Company and stakeholders, including the preparation and disclosure of complete, accurate, and reliable financial information and reports. In addition, the Board of Directors has established and reviewed the organization's risk management framework by assessing and analyzing both internal and external risk factors that affect the organization in order to implement them throughout the organization and use the organization's risk control systematically. The Board of Directors has assessed the adequacy of the Company's internal control system according to the SEC's internal control adequacy assessment form. By considering the internal control adequacy assessment form together with the internal control audit report, which was reviewed by Proud Advisory Company Limited, the Company's internal auditor, which is an external agency (Outsource), the results of the internal control adequacy assessment can be summarized according to the guidelines of The Committee of Sponsoring Organization of the Treadway Commission ("COSO"), which consists of 5 components, as follows: 1) Control Environment 2) Risk Assessment 3) Control Activities 4) Information & Communication 5) Monitoring From the assessment of the adequacy of the Company's internal control system, it was found that the Company has a good, appropriate, and adequate internal control system to operate in accordance with the organization's objectives. The details of the internal control adequacy assessment are as follows: The audit results have not revealed any material weaknesses from the assessment of the Company's internal control system, covering all 5 main components, which have been reviewed by the Audit Committee. In the past year, the auditors and the internal audit unit did not have any significant observations regarding internal control deficiencies. The Audit Committee and the Board of Directors have considered and are of the opinion that the Company's internal control system is adequate and appropriate for the size and nature of the Company's business, in accordance with relevant laws and regulations, and in accordance with the principles of good corporate governance (Good Corporate Governance) and compliance with the established internal control system. In addition, the Company has allocated sufficient personnel to effectively implement the internal control system. |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3160
Audit Committee's Opinion on the Head of Internal Audit
At the Board of Directors' Meeting No. 1/2025 held on February 21, 2025, the Audit Committee also attended the meeting to consider the adequacy assessment of the Company's internal control system. The summary of the opinion is that the Company has an adequate and effective internal control system. The Audit Committee has no different opinion from the opinion of the Board of Directors, and the Company's auditor has given an opinion that there are no material weaknesses in internal control over financial reporting. Securities and Exchange Commission and other laws related to the Company's business.
In 2024, the internal auditor conducted an audit and assessment of the internal control system. The scope of the internal control system audit covers a total of 10 processes as follows:
1) Revenue and Collection Cycle
2) Procurement and Disbursement Cycle
3) Inventory and Cost of Goods Sold/Services Management Cycle
4) Fixed Assets Management Cycle
5) Human Resources Management Cycle
6) Petty Cash and Cash Equivalents Management Cycle
7) IT General and Application Control Reviews
8) Personal Data Protection Act (PDPA)
9) COSO 2013 Internal Control and Corporate Governance (CG)
10) Compliance in SET, SEC Regulations and Laws
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
If Proud Advisory Company Limited, an outsourced company, with Mr. Prit Buapuen as the Head of Internal Audit appointed by the Audit Committee to be the Company's internal auditor, does not have adequate qualifications to perform the duties of the Company's internal auditor, including lacking independence in conducting audits and assessing the adequacy of the internal control system and compliance with the Company's systems, or performing duties ineffectively and inefficiently, the Company may remove, transfer, or terminate the aforementioned Head of Internal Audit.
Related Party Transactions
Introduction
The Company had related party transactions with individuals/legal entities that may have conflicts of interest during the accounting periods ended 31 December 2021, 31 December 2022, and 31 December 2023, as follows:
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| Mr. Choladhis Sinrachtanant | Person | Director/ Chief Executive Officer/ 0.29 percent shareholder | 2024-12-31T00:00 | |
| Dr. Chaiyot Denariyakul | Person | Director / Executive Vice President / 0.76 percent shareholder | 2024-12-31T00:00 | |
| Dr.Kongsak Techawibunphon | Person | Director / Chief Operating Officer / 0.86 percent shareholder | 2024-12-31T00:00 | |
| Cdr. Suwannee Jirayangyuen | Person | Director / Managing Director / 22.86 percent shareholder | 2024-12-31T00:00 | |
| The four related individuals are Dr. Choladhis Sinrachtanant, Dr. Chaiyot Denariyakul, Dr. Suwannee Jirayangyuen, Dr.Kongsak Techawibunphon | Juristic Person | Medical services | A group of physicians who are board members and executives with related characteristics | 2024-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 54409685.05 · Necessity: The company requires the expertise of all four physicians to perform procedures on service recipients according to their respective specializations as follows: 1. Dr. Choladhis Sinrachtanant - Procedural Physician 2. Dr. Suwannee Jirayangyuen - Pre-Procedure Assessment Physician 3. Dr. Chaiyot Denariyakul - Procedural Physician 4. Dr.Kongsak Techawibunphon - Anesthesiologist The company compensates physicians at a rate comparable to other physicians in the clinic, in accordance with the fee schedule policy. · Description: Annual physician fee, a cost of service. · As of yesteryear: 116300933.01 · Nature of transaction: The company pays compensation in the form of medical fees. · Audit committee opinion: The listed items are necessary and reasonable because the company compensates at a rate comparable to other physicians in the clinic, which is in line with the physician fee schedule policy. · As of year before yesteryear: 168166134.5 · 3931166.35 · Necessity: The company requires the expertise and skills of all four doctors to perform procedures on patients according to their respective specializations. · Description: The accrued doctor fees are expenses incurred in December, paid in January, and classified as other current liabilities. · As of yesteryear: 8386619.0 · Nature of transaction: Doctor's fee · Audit committee opinion: The aforementioned items are both necessary and reasonable as the company compensates at a rate comparable to other physicians within the clinic, in accordance with the physician fee schedule policy. · As of year before yesteryear: 14308781.25 |
Policy & Future Trends
Introduction
The Board of Directors' Meeting No. 1/2024 (Public Company) on February 23, 2023 considered and approved the Company's policy on related transactions. In order to make transactions correctly and appropriately in accordance with relevant laws and regulations. The Company is aware of its duty to comply with the rules regarding related party transactions or connected transactions as specified by the Stock Exchange, the Capital Market Supervisory Board, and the Securities and Exchange Commission.
Policy, Measures & Approval Process
There are criteria and procedures for conducting related transactions. or related transactions as follows: · Consideration of connected transactions. The Company will use the same price criteria and trade agreements as those used with general customers. As for the list of giving or receiving financial assistance It must be necessary and reasonable. And there must be fair terms and conditions. and create the greatest benefit to the company · In the case where there is no such price criteria for reference. The Company will consider comparing the price of products or services with external prices under the same or similar conditions. · The Company may make use of the reports of independent assessors appointed by the Company to compare prices for key inter-operation transactions to ensure that such prices are reasonable and in the best interests of the Company. · Directors, executives, or related persons may transact with the company or subsidiary only after such transaction has been approved by the company's shareholder meeting. Unless the transaction is a commercial agreement in the same manner that a reasonable person would deal with a normal contracting party in the same situation with trade bargaining power without influence from his or her status as a director, executive, or person with relevant, as the case may be, and is a commercial agreement approved by the committee or in accordance with the principles approved by the committee. · If the company has related transactions or other connected transactions. that meets the requirements of the Stock Exchange Capital Market Supervisory Board and the Securities and Exchange Commission The company must strictly comply with such requirements. · The company must disclose information about transactions that may have conflicts of interest. Related items or related transactions According to the rules of the Stock Exchange The Capital Market Supervisory Board and the Securities and Exchange Commission determine It is disclosed in the annual information disclosure form and annual report or any other report form and information on related transactions has been disclosed to the Stock Exchange. According to the regulations of the Stock Exchange as well as transactions related to the company. According to accounting standards. There must be a review of connected transactions according to the audit plan, with the internal audit department reporting to the Audit Committee. There are measures to control, inspect, and oversee that there is a random review of actual transactions, correctness, and compliance with the contract or policy or conditions specified.
Future Trends in Related Party Transactions
Related transactions that may occur in the future The company will comply with the laws regarding securities and the stock exchange and the regulations, announcements, orders or requirements of the Stock Exchange of Thailand. Those who may have conflicts or have interests in related transactions will not have the right to vote on such related transactions. Such related transactions must be considered according to the company's related transactions policy. According to the resolution of the Board of Directors' Meeting No. 1/2023 (Public Company) on February 23, 2023, in order to comply with the nature of normal trade operations and be a market price that can be compared or referenced with the price conditions at the company. Acting with third parties other than this, entering related transactions must be considered for necessity and appropriateness of price by the Audit Committee. However, if the audit committee does not have expertise in related transactions that may occur The Company will consider having an independent evaluator, independent specialist or the Company's auditor give an opinion on such related transactions for the Audit Committee to make decisions and provide opinions to the Board of Directors or shareholders, depending on case.

